vancomycin-resistant enterococci | GenomeWeb

vancomycin-resistant enterococci

NEW YORK (GenomeWeb News) — IMDx said today that its IMDx VanR assay for the Abbott m2000 platform has received regulatory clearance from Health Canada and Singapore's Health Sciences Authority, allowing the test to be sold and distributed in those countries.

As one of its major molecular diagnostics-related revenue sources begins to slow down, Qiagen today outlined its plan to replace it with several new MDx initiatives and other molecular biology-related growth drivers.

NEW YORK (GenomeWeb News) – IntelligentMDx today announced it has received clearance from the US Food and Drug Administration for its molecular diagnostic test for vancomycin-resistant enterococci.

Seegene this week introduced the Anyplex II STI-7 detection assay, a multiplex real-time PCR assay for several sexually transmitted infectious agents.

The collaboration will combine microfluidic PCR technology licensed from Caliper Life Sciences and various innovations from Canon's imaging and printing products with sample prep, digital PCR, and sequencing components from UMD researchers.

The new funds follow a $3.3 million Series C financing round closed in late 2009. MDI will use the money to further develop its pipeline of qualitative real-time PCR in vitro diagnostic tests for infectious diseases.

Cepheid also recently inked sole-source agreements with two separate entities to conduct surveillance of methicillin-resistant Staphylococcus aureus using its GeneXpert platform, company officials said last week.

An analyst with William Blair & Co. upgraded Cepheid shares to "outperform" from "market perform."

The FDA cleared Cepheid's Xpert vanA test for the antimicrobial resistance gene most commonly associated with vancomycin-resistant enterococci.

The test runs on Cepheid's RT-PCR-based GeneXpert System. The FDA-cleared Xpert vanA test will be available for shipment to customers this month.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.